Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

First Patient Enrolled in Phase III Clinical Trial of Boan Biotech's Nivolumab Injection

Tuesday, October 31, 2023

Boan Biotech announced today that the first patient in Phase III clinical trial of its Nivolumab Injection in China has been enrolled BA is the first biosimilar to Opdivo to undergo a Phase III study in China

Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC

Tuesday, October 31, 2023

Bridge Biotherapeutics a South Korean clinicalstage biotech company developing novel drugs for cancer fibrosis and inflammation announced that the company has initiated the Phase clinical trial evaluating the safety

Sun Pharma and Zydus Sign Licensing Agreement for Co-marketing of Desidustat, a Critical Treatment Option for Chronic Kidney Disease Patients in India

Monday, October 30, 2023

Sun Pharmaceutical Industries Limited Reuters SUNBO Bloomberg SUNP IN NSE SUNPHARMA BSE Sun Pharma and includes its subsidiaries andor associate companies and Zydus Lifesciences Limited

Coherus and Junshi Biosciences FDA Approve LOQTORZI™ for Nasopharyngeal Carcinoma

Saturday, October 28, 2023

Coherus BioSciences Inc and Shanghai Junshi Biosciences Co Ltd today announced that the US Food and Drug Administration approved LOQTORZI in combination with cisplatin and gemcitabine for the firstline treatment of adults with metastatic

Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China

Friday, October 27, 2023

Fapon a leading life sciences company entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA that granted Fapon an exclusive license to utilize the pancreatic stone protein biomarker for sepsis diagno...

Clarity and PSI Kick Off SAR-bisPSMA Phase III

Friday, October 27, 2023

Clarity Pharmaceuticals a clinical stage radiopharmaceutical company with a mission to develop nextgeneration products that improve treatment outcomes for children and adults with cancer and PSI CRO AG

Skye Bioscience Announces Positive Phase 1 Trial Results for SBI-100 Ophthalmic Emulsion, Its First-in-Class CB1 Agonist Being Developed for the Treatment of Glaucoma

Thursday, October 26, 2023

Skye Bioscience Inc a pharmaceutical company developing drugs targeting the endocannabinoid system initially focused on the CB receptor to address glaucoma and metabolic conditions

Renibus Announces First Patient Enrolled in PROTECT Phase 3 Study of RBT-1 to Reduce Post-operative Complications After Cardiothoracic Surgery

Thursday, October 26, 2023

Renibus Therapeutics a clinicalstage biopharmaceutical company focusing on the prevention and treatment of cardiorenal and metabolic diseases today announced that the first patient has been dosed in the pivotal Phase PROTECT trial

Roquette Introduces New Chapter in Moisture Protection with Launch of Three New Excipient Grades at CPHI Barcelona

Wednesday, October 25, 2023

Roquette a global leader in plantbased ingredients and leading provider of pharmaceutical and nutraceutical excipients is pleased to announce the addition of three new excipient grades to its unmatched portfolio of solutions

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.

Wednesday, October 25, 2023

Citius Pharmaceuticals Inc a biopharmaceutical company developing and commercializing firstinclass critical care products and TenX Keane Acquisition a publicly traded special purpose acquisition company